Vanguard International High Dividend Yield Index Fund Admiral Shares (VIHAX) is a mutual fund offered by The Vanguard Group Inc that seeks to track the performance of the FTSE All-World ex US High Dividend Yield Index. The fund provides investors with exposure to a diversified portfolio of high dividend-yielding equities from developed and emerging markets outside the United States; it invests primarily in common stocks of companies located in these markets that meet specific dividend yield criteria, excluding real estate investment trusts (REITs). VIHAX features a low expense ratio typical of Vanguard's Admiral Shares class, with a minimum initial investment requirement aimed at long-term investors seeking income and moderate growth.
The fund's holdings encompass large-, mid-, and small-cap stocks across various sectors including financials, energy, consumer staples, materials, and utilities; top positions often include established international dividend payers such as Novartis AG, Roche Holding AG, Nestle SA, Toyota Motor Corp, and HSBC Holdings plc. Geographic operations span over 40 countries, with significant allocations to Europe (e.g., Switzerland, United Kingdom, Germany), Asia-Pacific (e.g., Japan, Australia), and emerging markets like Taiwan, China, and South Korea; the fund maintains a market-cap weighted approach while applying screens for dividend sustainability and liquidity. Headquartered in Malvern, Pennsylvania, The Vanguard Group, founded in 1975, manages VIHAX as part of its extensive lineup of low-cost index funds, with no subsidiaries or parent company relationships directly impacting this fund.
Recent developments include adjustments to index methodology by FTSE Russell in 2023-2024 to enhance dividend quality screens amid global market volatility, resulting in portfolio rebalancing that reduced exposure to certain cyclical sectors; Vanguard announced minor fee reductions for select international funds including VIHAX in late 2024 to maintain competitiveness. The fund experienced net inflows exceeding $500 million in 2025 year-to-date amid investor shifts toward dividend strategies amid U.S. interest rate uncertainty under President Trump's administration. No major acquisitions, partnerships, or name changes have occurred for VIHAX within the last two years.